These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24711709)

  • 1. Tubulointerstitial disease in diabetic nephropathy.
    Tonolo G; Cherchi S
    Int J Nephrol Renovasc Dis; 2014; 7():107-15. PubMed ID: 24711709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
    Ruilope LM; Segura J
    Clin Ther; 2003 Dec; 25(12):3044-64. PubMed ID: 14749145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk of ESRD in type 1 diabetes: new strategies are needed to retard progressive renal function decline.
    Krolewski AS; Bonventre JV
    Semin Nephrol; 2012 Sep; 32(5):407-14. PubMed ID: 23062980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responding to the challenge of diabetic nephropathy: the historic evolution of detection, prevention and management.
    Vora JP; Ibrahim HA; Bakris GL
    J Hum Hypertens; 2000; 14(10-11):667-85. PubMed ID: 11095158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
    Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
    Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
    Zanella MT; Ribeiro AB
    Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy.
    Ibrahim HA; Vora JP
    Baillieres Best Pract Res Clin Endocrinol Metab; 1999 Jul; 13(2):239-64. PubMed ID: 10761865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protection by antihypertensive drugs: insights from microalbuminuria studies.
    Redon J
    J Hypertens; 1998 Dec; 16(12 Pt 2):2091-100. PubMed ID: 9886902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease.
    Agarwal R; Duffin KL; Laska DA; Voelker JR; Breyer MD; Mitchell PG
    Nephrol Dial Transplant; 2014 Dec; 29(12):2293-302. PubMed ID: 25085239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of glycosaminoglycans and sulodexide in the treatment of diabetic nephropathy.
    Abaterusso C; Gambaro G
    Treat Endocrinol; 2006; 5(4):211-22. PubMed ID: 16879000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury.
    Phillips AO; Steadman R
    Histol Histopathol; 2002 Jan; 17(1):247-52. PubMed ID: 11813875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing end-stage renal disease.
    Mogensen CE
    Diabet Med; 1998; 15 Suppl 4():S51-6. PubMed ID: 9868993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A story of microalbuminuria and diabetic nephropathy.
    Roshan B; Stanton RC
    J Nephropathol; 2013 Oct; 2(4):234-40. PubMed ID: 24475455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
    Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
    Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.